|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01332 TOUYUN BIOTECH
Nominal 
0.124 +0.035 (+39.326%) | 2025/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2024/06 HKD(K$) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | 2021/06 HKD(K$) | |
| Turnover | 36,581 | -49.921% | 73,047 | 104,345 | 166,063 | 139,197 |
| Cost of Sales | (23,033) | -43.970% | (41,108) | (68,437) | (107,725) | (84,780) |
| Gross Profit | 13,548 | -57.582% | 31,939 | 35,908 | 58,338 | 54,417 |
| 2025/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2024/06 HKD(K$) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | 2021/06 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 36,197 | -- | (49,145) | (85,081) | (86,308) | (71,874) | |
| Taxation | (11) | -- | 326 | (22) | (1,950) | (200) | |
| Profit / (Loss) from Discontinued Operations | (8,132) | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (16,811) | -- | 850 | 1,152 | 192 | 10,702 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 11,243 | -- | (47,969) | (83,951) | (88,066) | (61,372) | |
| 2025/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2024/06 HKD(K$) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | 2021/06 HKD(K$) | |
| Net Finance Costs / (Income) | 4,353 | -1.605% | 4,424 | 4,096 | 20,658 | 8,653 |
| Depreciation & Amortisation | 5,522 | -67.798% | 17,148 | 19,180 | 13,163 | 8,806 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/06 | 2023/06 | 2022/06 | 2021/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/06 | 2023/06 | 2022/06 | 2021/06 | |
| EPS (cts) | 0.400 | -- | -1.710 | -2.990 | -3.140 | -2.200 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | (0.023) | -- | (0.017) | 0.066 | 0.137 | 0.165 |
| Remarks: | Real time quote last updated: 11/09/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD 11,243 |
| %Change | -- |
| EPS / (LPS) | HKD 0.004 |
| NBV Per Share ($) | HKD -0.023 |